Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
The first wholesaler to offer insurance products for B2B and B2C firms in the Sharing Economy. Inlet aims provide insurance for assets that have been peer-to-peer rented for the short term, or for the provision of services such as letting properties online, as these markets are not currently covered by traditional insurances.
Inlet generates revenue from commissions via insurance products at the point of sale and at policy renewal. Income in the form of interest payments is also earned from customers that choose to pay via direct debit on a monthly basis, as well as from fees applied to customers who wish to amend their policies.
days to go:
Expired
investment:
£256,514
iBan Wallet has created an app which allows users to be in control of their finances, connecting them to the people involved in any transaction. They will create a space for investors and also for borrowers, allowing the borrowers to be in control of the amount of interest they pay.
days to go:
Expired
investment:
£111,648
Pynk is a fintech that is doing things differently—it relies on Artificial Intelligence, crowd wisdom and expert analysis to boost social investing, allowing its users commission-free investing. Users on the Pynk platform make short term price predictions and long term forecasts on financial assets. Pynk then aggregates the data and runs it through its 'Rose' AI and experts team to give accurate trading and investment analyses. The platform has more than 27,000 users from over 180 countries. Pynk also won the 'Best AI' startups award at the AIBC Blockchain Summit in Malta. It is also a part of the London fintech accelerator programmes with National Westminster and Royal Bank of Scotland. The company will use the investment to launch a retail investor wallet in the 4th quarter of 2020, recruit £10 million Assets Under Management (AUM) by end of 2020, and build out its team across different verticals.
days to go:
Expired
investment:
£574,550
Ablrate.com is an FCA regulated peer to peer lending platform which connects lenders with borrowers for asset-backed loans. It was launched in late 2014 and has a community of 5000 lenders who have completed £1 million+ worth of loans per month to all sizes of businesses throughout the UK.
days to go:
Expired
investment:
£457,950
Leaseum is a Business to Business (B2B) Software as a Service (SaaS) provider based in London that offers white label capital raising portals to its clients and targets alternative investment managers who deal with private equity, venture capital, real estate, hedge funds and private credit. The company claims that fundraising for alternative investments is time consuming, expensive and involves many compliance and regulatory aspects. It aims to change this by bringing together all the tools needed to raise capital such as an investor portal, a Customer Relationship Management (CRM) system, an email marketing module, e-signature facility, and investor onboarding compliances. Leaseum claims that it allows its clients to streamline their fundraising processes and convert more leads into investors via its portal. It will use 40% of the investment to strengthen its sales team, 40% to strengthen its IT team, and 20% for marketing.
days to go:
Expired
investment:
£76,440
Business Finance Market (BFM) is a financial technology platform that stimulates the market towards Small and Medium Enterprises (SMEs) lending via data in the UK. BFM claims that SMEs are gradually being excluded from mainstream banking. The company cites that in 1988, 40% of all bank lending went to SMEs. BFM points out that lending today is closer to 4% with an estimated £22 billion funding gap to the 5.9 million UK SMEs. BFM asserts that almost 90% of SME loan applications are stuck due to a lack of choice and transparency when it comes to securing finance. BFM aspires to solve this dilemma. It states that its technology allows SMEs to experience quicker finance decisions based on true addressable market access and allows lenders and intermediaries access to its platform to help manage the end-to-end application process, improve deal flow, and deliver faster credit decisions. BFM intends to exit via a trade sale within the financial sector.
days to go:
Expired
investment:
Withheld
